Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) generates frequent news as an international provider of consumer cannabis products operating across medical and adult-use markets. Company updates often highlight its portfolio of brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, and how these brands are deployed through retail dispensaries and international channels.
News coverage for Curaleaf commonly includes corporate and regulatory developments, such as its announced intention to seek shareholder approval for a proposed arrangement to continue from British Columbia, Canada to Delaware in the United States. This proposed domestication is described by the company as a way to align its corporate structure with its operational focus while maintaining its listings on the Toronto Stock Exchange and OTCQX.
Investors and observers can also expect retail expansion and operational updates. Recent announcements have covered the opening and relocation of dispensaries, including Curaleaf Millcreek in Erie, Pennsylvania, and Curaleaf Cape Canaveral in Florida. These releases describe new store locations, in-store experience, and the availability of products such as premium flower, vapes and edibles under the company’s brands.
Curaleaf’s news flow further includes transaction and financing announcements, such as its binding commitment to acquire, and later the termination of that commitment for, The Cannabist Company’s Virginia assets, and the upsizing of its revolving credit facility with Needham Bank from $40 million to $100 million. In addition, the company issues financial results releases, including quarterly reports prepared under U.S. GAAP that detail segment revenue, margins, cash flow and non-GAAP performance measures.
Beyond financial and operational items, Curaleaf also reports on community and social initiatives like its Feed the Block fundraiser to address food insecurity and partnerships with organizations such as the Baldwin Fund. For those tracking CURLF, this news page brings together these various categories of updates in one place.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) will release its fourth quarter and fiscal year financial results for 2022 on May 1, 2023, after market close. A conference call is scheduled for the same afternoon at 5:00 p.m. ET, featuring a presentation followed by a Q&A session to discuss operational highlights. The company operates in 19 states across the U.S. and runs 152 dispensaries, employing nearly 5,500 staff. Curaleaf is recognized as a leading provider in the cannabis sector, emphasizing quality and accessibility in both medical and adult-use markets.
Interested parties can access a replay of the call until May 5, 2023. For more details about Curaleaf and its offerings, visit Curaleaf's investor relations site.
Curaleaf Holdings, Inc. announced a review by its Audit Committee, leading to adjustments in revenue figures for 2021 and 2022. The adjustments indicate a 1.25% reduction in 2021 revenue and a 0.75% reduction in 2022 revenue. The company anticipates its total revenue for 2022 to be approximately $1.337 billion, with the fourth quarter expected to generate around $352 million. As a result of the review, Curaleaf's previously reported financial statements for these periods will be restated, and reliance on previously issued financial results is discouraged. The company aims to enhance internal controls and ensure accurate reporting moving forward. Curaleaf is set to file its restated financial statements by May 1, 2023.
On April 17, 2023, Curaleaf Holdings announced that the New Jersey Cannabis Regulatory Commission (CRC) reversed its prior decision and approved the renewal of Curaleaf's adult use cannabis licenses following a legal challenge. This decision came after an earlier vote on April 13, which had denied the renewals. Curaleaf's CEO, Matt Darin, expressed that this was a significant victory for the company's 500 NJ employees, confirming their compliance with CRC requirements. The CRC's prior denial was amidst recommendations for renewal from its staff, highlighting no pending violations against Curaleaf. Additionally, the company will provide further details on its labor practices to maintain compliance with New Jersey laws. Curaleaf has generated substantial tax revenues and invested over $75 million in the state's cannabis industry.
Curaleaf Holdings, Inc. (OTCQX: CURLF) announced its disappointment over the New Jersey Cannabis Regulatory Commission's decision to deny the renewal of its cultivation and retail licenses for adult-use. The CRC Board overrode its own staff's recommendation for renewal, a move that Curaleaf's Chairman, Boris Jordan, argues is unfounded as the company has never faced a violation and is in good standing with the CRC. Curaleaf aims to resolve the situation and continue operations in New Jersey. The company emphasizes its commitment to legality and compliance, indicating plans to pursue all necessary means to renew its licenses and sustain its business in the state.
Curaleaf Holdings is expanding its presence in Florida by opening its 59th and 60th dispensaries, located in Boca Raton and West Palm Beach, respectively. The Boca Raton location is now operational, while the West Palm Beach site is expected to open by the end of April 2023, pending regulatory approvals. This expansion brings Curaleaf's total dispensary count to 151 nationwide. Additionally, starting April 21, the company will introduce its Grassroots brand in Florida, known for premium cannabis flower and pre-rolls. The Grassroots products will enhance the company’s portfolio and cater to a diverse range of cannabis consumers. Curaleaf emphasizes its commitment to customer loyalty through its revamped rewards program, allowing patients to earn points on purchases at any Curaleaf dispensary nationwide.